Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS3A pseudogene 51 (RPS3AP51)
- Target
- RPS3AP51
- Molecular classification
- Other (Processed pseudogene)
01
Overview
RPS3A pseudogene 51 is a processed genomic pseudogene derived from the ribosomal protein S3A gene. It is one of at least 60 processed pseudogenes originating from the RPS3A gene dispersed throughout the human genome. Unlike the functional RPS3A protein—which is a structural component of the ribosomal 40S subunit essential for protein synthesis—RPS3AP51 does not encode a protein and does not contribute to ribosomal function or any biological processes. There is no evidence in the literature of disease association, functional activity, or drug interaction for this pseudogene. Its existence is primarily relevant to genomic annotation rather than to molecular pharmacology or biomedical research contexts.
- Other names
- RPS3AP51
02
Mechanism of action
None. There are no mechanisms of action relevant to this pseudogene sequence
03
Biological functions
None known; pseudogenes generally do not encode functional proteinsSometimes pseudogenes may regulate parent gene expression through RNA-mediated or epigenetic mechanisms in rare cases, but no such function is described or attributed for RPS3AP51
04
Disease associations
None directly attributed; pseudogenes overall may sometimes serve as biomarkers or play indirect roles in disease, but no specific role has been published for RPS3AP51The parent gene RPS3A has been associated with diseases, but RPS3AP51 itself has no documented disease relationship
05
Safety considerations
None. Pseudogenes do not encode functional proteins and present no known safety concerns in the context of therapeutics, diagnosis, or monitoring
Beyond the preview
Go deeper on RPS3A pseudogene 51 (RPS3AP51).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RPS3A pseudogene 51 (RPS3AP51).